(Q35452743)

8 August 2017

title

The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus (English)

1 reference

8 August 2017

0 references

1 reference

Agus Lastya

1

1 reference

8 August 2017

Made Ratna Saraswati

series ordinal

2

1 reference

8 August 2017

Ketut Suastika

series ordinal

3

1 reference

8 August 2017

publication date

26 November 2014

1 reference

8 August 2017

1 reference

8 August 2017

volume

7

1 reference

8 August 2017

page(s)

849

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-0500-7-849

8 August 2017

exact match

0 references

cites work

Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

GIP and GLP-1, the two incretin hormones: Similarities and differences

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents

27 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-0500-7-849

Decreased glucagon-like peptide 1 fasting levels in type 2 diabetes.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-0500-7-849

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-0500-7-849

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417523

26 September 2018

Identifiers

DOI

10.1186/1756-0500-7-849

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference